胸腺肽治疗免疫性血小板减少性紫癜效果观察  

THE EFFECT OBSERVATION OF THE TREATMENTOF IMMUNITY THROMBOCYTOPENIA PURPURAWITH THYMOPEPTIDUM

作　　者：杨自杰[1] 冯亚春[1] 周承[1] 孙精明[2] 王凤英[3] 崔艳秋[3] 

机构地区：[1]齐齐哈尔医学院第一附属医院血液科 [2]齐齐哈尔医学院免疫学教研室 [3]齐齐哈尔市第一医院

出　　处：《齐齐哈尔医学院学报》1994年第2期61-62,共2页Journal of Qiqihar Medical University

摘　　要：应用胸腺肽治疗免疫性血小板减少性紫癜(ITP)患者11例，剂量为40mg／日，静脉滴注，疗程为1～4个月，其中2例显效，8例良效，血小板较治疗前上升30×10^9／L，并维特2个月以上。本药副作用轻微，11例中仅1例出现荨麻疹，证明胸腺肽治疗免疫性血小板减少性紫癜具有可行性。11 cases of immunity thrombocytopentia purpura(ITP) were treated with thymopeptidum of 40 mg/d iv drop. 2 cases achieved excellent effects after therapy, 8 cases obtained good effects. Their BPC rosed above that of the pre-treatment value 30×109/L and maintained at least 2 months. The side effects of thymopeptidum was tiny, only one case appea r urticaria. It proved that the treatment of .ITP with thymopeptidum was effective.

关 键 词：治疗前 免疫性血小板减少性紫癜 胸腺肽 效果观察 ITP 静脉滴注 患者 证明 上升 应用 

分 类 号：R554.6[医药卫生—血液循环系统疾病] R759.1[医药卫生—内科学]